Evolent Health, Inc.

Evolent connects care for individuals with complex conditions such as cancer, cardiovascular disease, and musculoskeletal diagnoses. The company works with health plans and other risk-bearing entities and payers, supporting physicians and other healthcare providers in delivering high-quality, evidence-based care to their patients. Evolent believes that adhering to evidence-based clinical pathways leads to improved patient outcomes, a better experience for physicians, and reduced healthcare system costs. Specialty care constitutes a significant and rapidly expanding portion of healthcare costs in the United States, partly due to the rapid development of new therapies and treatments. Evolent aims to provide an integrated approach to a patient's condition across multiple specialties, utilizing technology to recommend evidence-based clinical pathways. This approach offers rapid feedback to providers, seeks to eliminate barriers to care, and aligns financial incentives with the best evidence. Evolent was founded in 2011 by its management team members, UPMC, and The Advisory Board Company, to enable providers to adopt a value-based business model. The company has expanded through organic growth and acquisitions, focusing on companies experienced in assisting customers with managing large and complex specialties including oncology, cardiology, radiology, musculoskeletal, physical medicine, and genetics care. Evolent operates with one operating segment and one reportable segment.